ScopusElsevier Scopus
Status
Active
Coverage
2009–present
Source type
Journal
Open access
Yes
CiteScore
6.2
SJR · SCImago
1.416
Q1 SJR quartile
H-index
80
Best quartile
Q1 · 76th pctile
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 100 / 428 | 76th | Q1 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology is Scopus-indexed (Q1, CiteScore 6.2), WoS SCIE, DOAJ. Published by SAGE Publications Inc..
Checked against the index lists dated .
ISSN 1758-8340Verify ISSN ↗1758-8359Verify ISSN ↗
Publisher: SAGE Publications Inc.
Scopus · Q1WoS · SCIEOpen Access
6.2
CiteScore 2025
Q1
Best quartile
3
Indexed in
Cost to publish: Checking DOAJ for article charges…
Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
DOAJDirectory of Open Access Journals (live)
Listed in DOAJ
Open accessFully open access, peer reviewed
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Therapeutic Advances in Medical Oncology indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2009–present, best quartile Q1, CiteScore 6.2.
What quartile is Therapeutic Advances in Medical Oncology in Scopus?
Therapeutic Advances in Medical Oncology is Q1 in Oncology (rank 100 of 428), by CiteScore 2025.
What is the impact factor of Therapeutic Advances in Medical Oncology?
Therapeutic Advances in Medical Oncology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 6.2, which places it in quartile Q1 at the 76th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.416, quartile Q1, with an H-index of 80.
How much does it cost to publish in Therapeutic Advances in Medical Oncology?
The publisher lists an article processing charge of about US$2,800 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Who publishes Therapeutic Advances in Medical Oncology and what is its ISSN?
Therapeutic Advances in Medical Oncology is published by SAGE Publications Inc. Its print ISSN is 1758-8340 and its online ISSN is 1758-8359.
Is Therapeutic Advances in Medical Oncology in Web of Science?
Yes — indexed in the Science Citation Index Expanded.
Is Therapeutic Advances in Medical Oncology open access?
Yes — it is an open-access journal, listed in DOAJ.
How well cited is Therapeutic Advances in Medical Oncology? — open metrics via OpenAlex
Therapeutic Advances in Medical Oncology has an h-index of 91 and a 2-year mean of 3.68 citations per paper (OpenAlex). Its Scopus CiteScore is 6.2, quartile Q1. On 2-year citations it ranks #87 of 424 Scopus journals in Oncology.
91
h-index
3.68
2-yr mean citations
969
i10-index
1,963
works indexed
45,713
total citations
Publication fee · open access list price, US$
US$2,800
2-yr mean citations, among Scopus journals in the same subject
#87 of 424 Top 21% Oncology
Therapeutic Advances in Medical Oncology published 279 papers in 2025. 2026* is the year so far.
Main topics
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Therapeutic Advances in Medical Oncology? — latest 100 articles, 2026
In its latest 100 research articles (2026), authors are most often from China (50.1%), United States (10.2%) and Japan (5.1%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Therapeutic Advances in Medical Oncology? — indicators, not proof of misconduct
Scopus status: Active. 18 retracted papers are recorded (9.2 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers 18 · 9.2 per 1,000 papers
- Problematic Paper Screener flags None flagged
- Author concentration50.1% of recent authorship from China
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journals Journal Indexed in
Therapeutic Advances in Musculoskeletal Disease Scopus Q1 WoS SCIE DOAJ Therapeutic Advances in Psychopharmacology Scopus Q1 WoS SCIE DOAJ Therapeutic Advances in Urology Scopus Q1 WoS SCIE DOAJ Topics in Early Childhood Special Education Scopus Q1 WoS SSCI Toxicologic Pathology Scopus Q2 WoS SCIE Trends in Amplification Not in these indexes Trends in Hearing Scopus Q1 WoS SCIE DOAJ Tropical Conservation Science Scopus Q2 WoS SCIE
← Back to Journal Finder
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.